|
|
||||||||
From the Department of Neurology, Molecular Medicine (Drs. Hu and K.-Y. Lee), Family Medicine (Dr. Wong), Taipei Municipal Jen-Ai Hospital; Taipei City Psychiatry Center (Drs. Sung and Liu); Graduated Institute of Biomedical Technology (W.-C. Hsu), Taipei Medical College; Division of Molecular Medicine, Department of Medical Research (Drs. C.-C. Lee, Tsai, and Chang), China Medical College Hospital, Taiwan.
Address correspondence and reprint requests to Dr. Jan-Gowth Chang, Division of Molecular Medicine, Department of Medical Research, China Medical College Hospital, 2, Yu-Der Road, Taichung, Taiwan.
The alpha-2 macroglobulin five-nucleotide deletion (A2M-2) allele frequency was not significantly higher in the AD group than the control group (0.062 versus 0.101, p > 0.1). The odds ratio for AD in individuals with the A2M-2 allele was 0.582 (95% CI, 0.25 to 1.40). These results do not support the association between A2M-2 and AD in the Chinese population, although the allele frequency of A2M-2 is lower than that found in the Caucasian population. Therefore, A2M-2 might not be a significant risk factor of AD among Taiwan Chinese.
This article has been cited by other articles:
![]() |
A. J. Saunders, L. Bertram, K. Mullin, A. J. Sampson, K. Latifzai, S. Basu, J. Jones, D. Kinney, L. MacKenzie-Ingano, S. Yu, et al. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin Hum. Mol. Genet., November 1, 2003; 12(21): 2765 - 2776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Koster, B. Dermaut, M. Cruts, J. J. Houwing-Duistermaat, G. Roks, J. Tol, A. Ott, A. Hofman, G. Munteanu, M. M. B. Breteler, et al. The {{alpha}}2-macroglobulin gene in AD: A population-based study and meta-analysis Neurology, September 12, 2000; 55(5): 678 - 684. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |